NCT02591108

Brief Summary

The assessment of neuromuscular blockage is common practice in the operating room, in which such agents are employed. Still today, the use of simple hand held stimulators and visual monitoring of these responses are the norm. The investigators want to study the potential for employing a non-invasive quantitative device with built in sensors that will hopefully accurately determine the degree of neuromuscular blockade. This system utilizes commonly employed train of four (TOF) electrical stimulation pulses, an incorporated force sensor and an automated detection system. This system will not only utilized pre-blockade, but also throughout an entire surgical procedure and during reversal therapy. For comparisons, the investigators will use both the prototype device and a standard hand held TOF for the assessment of neuromuscular blockage. In other words, the planned protocol will involve testing the effectiveness and accuracy of the device concurrently with peripheral nerve stimulation, during a procedure as is done for the current standard of care. All protocols will be carried out under the direct guidance and supervision of anesthesiologists and/or nurse anesthetists.

Trial Health

15
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Jan 2018

Typical duration for not_applicable

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 18, 2015

Completed
8 months until next milestone

First Posted

Study publicly available on registry

October 29, 2015

Completed
2.2 years until next milestone

Study Start

First participant enrolled

January 1, 2018

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2018

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2019

Completed
Last Updated

March 2, 2018

Status Verified

February 1, 2018

Enrollment Period

10 months

First QC Date

March 18, 2015

Last Update Submit

February 28, 2018

Conditions

Keywords

train of fourneuromuscular blockadesurgery

Outcome Measures

Primary Outcomes (1)

  • Quantitative Amplitude of Force in the Neuromuscular Block Aid compared to the Qualitative Standard of Care Observations

    FDA clinical trials have utilized \~100-400 patients to determine the relative safety and efficacy of a medical device. Direct comparison of the devices qualitative evaluation of scoring from the administering anesthesiologist will be used for the final analysis. A peripheral nerve stimulator, used to elicit a train-of-four (TOF) response, allows the assessment of neuromuscular blockade. Subjectively they determine the relative depth by visualizing TOF responses.If the first and last stimulus in a TOF elicit no force, this indicates blockade, or if the TOF has equal amplitudes, this indicates no blockade or reversal. Return of muscle force is required before the patient can be extubated. Current peripheral nerve stimulators rely on visual subjective analysis of relative contractions, whereas our investigational device will provide a quantitative assessment of the amplitude of the muscle contraction in grams and percent amplitudes of measured forces relative to the first stimulus.

    2 years

Study Arms (2)

Safety and Efficacy

EXPERIMENTAL

Parallel treatment; use of standard TOF peripheral Stimulator to Novel Train of Four Device

Device: Neuromuscular Block AidDevice: Standard of Care: Microstim Plus

Microstim

ACTIVE COMPARATOR

A peripheral nerve stimulator, also known as a train-of-four monitor, is used to assess neuromuscular transmission when neuromuscular blocking agents (NMBAs) are given to block musculoskeletal activity. By assessing the depth of neuromuscular blockade, peripheral nerve stimulation/monitoring can ensure proper medication dosing and thus decrease the incidence of side effects. Peripheral nerve stimulation is most commonly used for ongoing monitoring in the intensive care unit (ICU).

Device: Neuromuscular Block AidDevice: Standard of Care: Microstim Plus

Interventions

Neuromuscular Block Aid, is a quantitative mechansim for collecting the the train-of-four and can be kept in an electronic medical record, also known as a train-of-four monitor, is used to assess neuromuscular transmission when neuromuscular blocking agents (NMBAs) are given to block musculoskeletal activity. By assessing the depth of neuromuscular blockade, peripheral nerve stimulation/monitoring can ensure proper medication dosing and thus decrease the incidence of side effects. Peripheral nerve stimulation is most commonly used for ongoing monitoring in the intensive care unit (ICU).

Also known as: Peripheral Nerve Stimulator - Train of Four Monitoring
MicrostimSafety and Efficacy

A peripheral nerve stimulator, also known as a train-of-four monitor, is used to assess neuromuscular transmission when neuromuscular blocking agents (NMBAs) are given to block musculoskeletal activity. By assessing the depth of neuromuscular blockade, peripheral nerve stimulation/monitoring can ensure proper medication dosing and thus decrease the incidence of side effects. Peripheral nerve stimulation is most commonly used for ongoing monitoring in the intensive care unit (ICU).

MicrostimSafety and Efficacy

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Normal, healthy subjects (adults) admitted for surgical procedures.

You may not qualify if:

  • Under 18 years of age or over 80 years of age, anesthetic paradigm does not include NMBAs.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (2)

  • Hong JB, Iaizzo PA. Force assessment of the stimulated arm flexors: quantification of contractile properties. J Med Eng Technol. 2002 Jan-Feb;26(1):28-35. doi: 10.1080/03091900110099558.

  • Hong J, Falkenberg JH, Iaizzo PA. Stimulated muscle force assessment of the sternocleidomastoid muscle in humans. J Med Eng Technol. 2005 Mar-Apr;29(2):82-9. doi: 10.1080/03091900412331271158.

Study Officials

  • Paul A Iaizzo, PhD

    University of Minnesota

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 18, 2015

First Posted

October 29, 2015

Study Start

January 1, 2018

Primary Completion

November 1, 2018

Study Completion

November 1, 2019

Last Updated

March 2, 2018

Record last verified: 2018-02

Data Sharing

IPD Sharing
Will not share